Close Menu

NEW YORK (GenomeWeb) – Metabolon announced today that it has partnered with Israeli precision medicine firm InnVentis to study metabolomics in individuals with chronic inflammatory diseases such as rheumatoid arthritis.

The deal joins Metabolon's metabolomics expertise with InnVentis' big data and machine learning platform, the company said. Specific terms of the partnership were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Following its departure from the European Union, the UK is to implement a fast-track visa program aimed at attracting scientific talent to Britain, according to BBC News.

ScienceInsider reports that researchers in Brazil are concerned that a creationist was chosen to run the agency that oversees graduate study programs there.

The Washington Post reports that researchers are quickly analyzing the coronavirus that has been causing illness and sharing their findings.

In PLOS this week: common variant associated with BMI in Arctic populations, analysis of microRNA markers associated with being born small for gestational age, and more.